Comparisons among other mobilizing chemotherapy reimens suggested that vinorelbine showed superior efficacy than gemcitabine in MM patients, the addition of methotrexate (MTX) to MEOD (mitoxantrone, etoposide, vindesine and dexamethasone) plus G-CSF can improve mobilization efficacy in NHL patients [38, 64]. This evidence concerns the gene CSF3 and non-Hodgkin lymphoma.